Peptide-based vectors have received awareness for their specificity in binding to receptors overexpressed in breast cancer cells, perhaps overcoming worries connected to lower internalization. Co-formulation with other permeation enhancers, enzyme inhibitors, and hydrogels have also been used to allow the oral administration of other peptide medication, for example octreotide and https://charlesm009ekn5.estate-blog.com/profile